Contemporary Results of Carotid Endarterectomy for Asymptomatic Carotid Stenosis
- 1 May 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 41 (5) , 975-979
Abstract
Background and Purpose— The validity of carotid endarterectomy (CEA) for asymptomatic carotid stenosis has been questioned recently due to the increasing effectiveness of medical management. In this study, we evaluated how contemporary outcomes of CEA for asymptomatic carotid stenosis compare with published stroke rates for best medical management. Methods— We identified all patients who underwent CEA for asymptomatic carotid stenosis from the 2005, 2006, and 2007 National Surgical Quality Improvement Program (NSQIP) database. Pre- and postoperative variables, including 30-day stroke, death, and myocardial infarction, were analyzed. Results— Of 10 423 carotid endarterectomies identified, 5009 were for asymptomatic carotid stenosis. The stroke, death, and myocardial infarction rates of this group were 0.96%, 0.56%, and 0.22%, respectively. If the 0.96% perioperative stroke rate from our contemporary NSQIP analysis is combined with the 5-year stroke risk after CEA of 3.8% from the Asymptomatic Carotid Surgery Trial, the average annual stroke rate is 1%, comparable to the stroke rate of 0.8% for best medical management from the Second Manifestations of Arterial Disease Study trial. Conclusions— These contemporary results show that stroke rates with CEA and best medical management for asymptomatic stenosis are similar. Despite limitations, our results emphasize the importance of continuing randomized prospective trials comparing CEA and best medical management for asymptomatic carotid stenosis.Keywords
This publication has 27 references indexed in Scilit:
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Symptomatic Carotid Stenosis: Endarterectomy, Stenting, or Best Medical Management?Seminars in Vascular Surgery, 2008
- Interventions for carotid artery disease: time to confront some ‘inconvenient truths’Expert Review of Cardiovascular Therapy, 2007
- High-Dose Atorvastatin after Stroke or Transient Ischemic AttackNew England Journal of Medicine, 2006
- Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trialThe Lancet, 2004
- Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary EventsNew England Journal of Medicine, 2001
- Validating risk-adjusted surgical outcomes: chart review of process of careInternational Journal for Quality in Health Care, 2001
- The Fall and Rise of Carotid Endarterectomy in the United States and CanadaNew England Journal of Medicine, 1998
- Do the facts and figures warrant a 10-fold increase in the performance of carotid endarterectomy on asymptomatic patients?Neurology, 1996
- Endarterectomy for Asymptomatic Carotid Artery StenosisJAMA, 1995